Cloxacillin Dosing for Pediatric Bacterial Infections
For pediatric patients with suspected or confirmed staphylococcal skin and soft tissue infections, oral cloxacillin (or dicloxacillin) should be dosed at 25-50 mg/kg/day divided into 4 doses, with intravenous cloxacillin/flucloxacillin at 50 mg/kg every 6 hours (QDS) for severe infections requiring parenteral therapy. 1
Oral Dosing for Outpatient Management
- For impetigo and uncomplicated skin infections: Dicloxacillin 25-50 mg/kg/day divided into 4 doses orally is the standard pediatric dosing 1
- For methicillin-susceptible Staphylococcus aureus (MSSA) skin and soft tissue infections: The same dosing applies (25-50 mg/kg/day in 4 divided doses) 1
- Treatment duration: Typically 7-10 days depending on clinical response 1
Important caveat: Dicloxacillin is noted as "not used much in pediatrics" in current U.S. practice, with cephalexin (25-50 mg/kg/day in 3-4 divided doses) being preferred due to better suspension availability and less frequent dosing requirements 1
Intravenous Dosing for Severe Infections
- For mastoiditis: Cloxacillin/flucloxacillin 50 mg/kg QDS (every 6 hours) IV for 10 days 1
- For osteomyelitis (age >3 years): Cloxacillin/flucloxacillin 50 mg/kg QDS IV for 10 days, then switch to oral therapy (total 3 weeks) 1
- For suspected staphylococcal pneumonia: Cloxacillin 50 mg/kg QDS IV for 7-10 days, then switch to oral (total 3 weeks therapy) 1
- For infant sepsis with suspected staphylococcal infection: Flucloxacillin 50 mg/kg QDS IV for 7-10 days (3 weeks for meningitis) plus gentamicin 1
Penicillin Allergy Considerations
Critical distinction: The question mentions penicillin allergy, but cloxacillin/dicloxacillin ARE penicillins (penicillinase-resistant penicillins) and are absolutely contraindicated in patients with true penicillin allergy 1
Alternative Agents for Penicillin-Allergic Patients:
- For non-immediate hypersensitivity reactions: Cephalexin 25-50 mg/kg/day in 3-4 divided doses orally, or cefazolin 50 mg/kg/day in 3 divided doses IV 1
- For immediate hypersensitivity or severe allergy: Clindamycin 20-30 mg/kg/day in 3 divided doses orally for mild infections, or 25-40 mg/kg/day in 3 divided doses IV for severe infections 1
- For MRSA coverage in allergic patients: Vancomycin 40 mg/kg/day in 4 divided doses IV (not to exceed 2 grams/day) 1
Specific Clinical Scenarios
Skin and Soft Tissue Infections (MSSA):
- Mild outpatient cases: Cephalexin preferred over dicloxacillin in pediatrics (25-50 mg/kg/day in 4 divided doses) 1
- Severe cases requiring hospitalization: Nafcillin or oxacillin 100-150 mg/kg/day in 4 divided doses IV is the parenteral drug of choice 1
Bacterial Lymphadenitis:
- Recent evidence demonstrates oral cloxacillin is non-inferior to amoxicillin-clavulanic acid for uncomplicated pediatric bacterial lymphadenitis, with mean defervescence time of 5.74 days 2
Critical Pitfalls to Avoid
- Never use cloxacillin/dicloxacillin in patients with documented penicillin allergy - this is a penicillin derivative and cross-reactivity is expected 1
- Inactive against MRSA - if community-acquired MRSA is suspected based on local epidemiology, purulent drainage, or treatment failure, switch to clindamycin, trimethoprim-sulfamethoxazole, or vancomycin 1
- Not first-line in U.S. pediatric practice - cephalexin has largely replaced dicloxacillin due to better palatability and dosing convenience 1
- Neonatal dosing differs significantly - the doses listed above are not appropriate for neonates; refer to specialized neonatal dosing guidelines 1
Monitoring and Follow-up
- Reassess within 48-72 hours of initiating therapy to evaluate clinical response 1
- Treatment failure indicators: Persistent fever beyond 48-72 hours, worsening erythema, or development of systemic symptoms warrant consideration of resistant organisms or alternative diagnoses 1
- Renal impairment: Dose adjustment may be necessary as cloxacillin half-life is prolonged in renal dysfunction 3